The Patient Partnership Index will return in 2026.
About the
Index
The Patient Partnership Index is a global initiative from the OVID Health team.
Launched in May 2020, the Index offers patient groups, pharmaceutical and biotech companies an opportunity to celebrate their patient partnerships. The aim is to showcase as many partnerships that meet the mark as possible, so we can raise the bar across the industry. Entering the Index is completely free for everyone and is seen as a vital part of reputation-building in patient engagement
The Index has a sole goal in mind: to improve patient outcomes through high quality patient-pharmaceutical partnerships in communications, advocacy, R&D, clinical trials and market access.
The concept of patient centricity is mainstream now in research and development, including in clinical trials and patient support programmes. But the Index looks beyond ‘centricity’ in R&D and into partnerships of equals for three reasons: one, because ‘centricity’ can be passive; two, it is traditionally tied to R&D; and three, because top quality communications between companies and patient groups is about collaborating as equals.
To keep up-to-date with opportunities to showcase your partnerships, register your interest.
To learn even more about how to create successful patient partnerships, you can also read our previous insights reports from 2022, 2021 and 2020.
Patient Advocacy
with OVID Health
Relationship
Audits
We can work across business functions to create a ‘patient promise’ plan of action on how to embed patient-centricity in communications and advocacy.
Co-Created
Campaigns
We are experts in bringing together pharmaceutical companies and patient groups to create and deliver impactful campaigns in a range of therapy areas.
Measurement &
Evaluation
Our Patient Centricity & Advocacy Tracker (PACT) is a proprietary measurement tool which companies can use to assess, track and demonstrate the quality of their patient centricity activities and, in time, anonymously benchmark themselves against competitors by producing a Patient Centricity (PACe) Score.
HCP
Engagement
We can support and advise pharmaceutical companies on how to deliver truly empowered engagement programmes with healthcare professionals (particularly in rare diseases).
Patient
Councils
We are experts in advising companies on best practice and models of convening and setting up patient advisory councils.
Capacity
Building
We can independently review your patient centricity in communications and advocacy, using the metrics developed for the Patient Partnership Index alongside bespoke support and practical advice.
